Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: Suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency
Rm. Popovici et al., Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: Suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency, J CLIN END, 86(6), 2001, pp. 2653-2659
Intrauterine growth restriction (IUGR) can be a consequence of decreased ut
erine blood flow (uteroplacental insufficiency) and maternal and fetal hypo
xia. Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs)
are key elements in fetal growth. IGF-I is a major growth promoter in uter
o. IGFBP-1 is primarily made in the Liver, and it mostly inhibits IGF actio
ns at the cellular level. IGFBP-1 is elevated in the fetal circulation of h
uman and animal pregnancies complicated by IUGR caused by placental insuffi
ciency and in utero hypoxia and is believed to restrict fetal growth by seq
uestering IGFs. In this study, we developed a protocol to establish highly
pure primary cultures of human fetal hepatocytes in vitro and investigated
their expression of IGFBP-1 messenger RNA (mRNA) and protein and the effect
s of hypoxia on their expression of IGFBP-1 mRNA and protein. Hepatocytes w
ere isolated from second-trimester human fetal livers (n = 7) and purified
by Percoll gradient centrifugation. Hepatocyte cultures were characterized
by immunocytochemistry and were compared with hepatocytes in situ in human
fetal liver tissue, by immunohistochemistry,using specific antibodies and i
ndirect immunofluorescence. Cultures consisted primarily (>90%) of cells po
sitive for cytokeratin 18, fibrinogen, and IGFBP-1, with less than 2% vascu
lar cells and less than 8% macrophages. Identification of isolated hepatocy
tes was further confirmed by morphology. Hepatocytes were cultured in defin
ed medium, and Northern analysis revealed expression of a 1.5-kb IGFBP-1 mR
NA transcript in hepatocytes cultured under normoxic conditions, for 24 h,
that did not increase in steady-state levels after 48 h in culture. Under h
ypoxic conditions (2% O-2), IGFBP-1 mRNA expression increased 3- to 4-fold,
compared with normoxic controls. Cells cultured under 10% O-2 did not demo
nstrate an increase in IGFBP-1 mRNA levels. IGFBP-1 protein in conditioned
medium (CM) was measured by immunoradiometric assay and increased 3- to 4-f
old under hypoxic (2% O-2), compared with normoxic, conditions. Western lig
and blot analysis of CM revealed the presence of IGFBP-1, IGFBP-2, IGFBP-3,
and IGFBP-4. IGFBP-1 was the most abundant IGFBP in CM, and densitometric
analysis revealed a 2.5-fold increase in IGFBP-1 under hypoxic, compared wi
th normoxic, conditions, supporting the immunoradiometric assay results. A
3-fold increase in IGFBP-3 mRNA, but not other IGFBPs, was noted under hypo
xic, compared with normoxic, conditions. This study demonstrates that human
fetal hepatocytes can be cultured in defined medium, as primary cultures w
ith high purity, and that they express IGFBP-1 mRNA and secrete IGFBP-1 pro
tein in vitro. In addition, the data demonstrate that hypoxia up-regulates
fetal hepatocyte IGFBP-1 mRNA steady-state levels and protein, with this be
ing the major IGFBP derived from the fetal hepatocyte. The data support a r
ole for the fetal liver as a source of elevated circulating levels of IGFBP
-1 in fetuses with in utero hypoxia and IUGR.